Neopharmed Gentili Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 380

Employees

  • Latest Deal Type
  • Div. Recap.
  • (Announced)

  • Financing Rounds
  • 6

  • Investments
  • 7

Neopharmed Gentili General Information

Description

Provider of research, development and distribution of medicines to its clients in the national pharmaceutical market. The company's products are in vascular and cardio-metabolic areas, pneumatological areas, antibiotics and supplements, offering clients a tangible impact that crosses multiple therapeutic areas.

Contact Information

Website
www.neogen.it
Formerly Known As
Gentili, Istituto Gentili
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Via S.G. Cottolengo, 15
  • 20143 Milan
  • Italy
+39 02
Primary Industry
Pharmaceuticals
Corporate Office
  • Via S.G. Cottolengo, 15
  • 20143 Milan
  • Italy
+39 02

Neopharmed Gentili Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neopharmed Gentili Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neopharmed Gentili‘s full profile, request access.

Request a free trial

Neopharmed Gentili Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of research, development and distribution of medicines to its clients in the national pharmaceutical market. Th
Pharmaceuticals
Milan, Italy
380 As of 2023

Kilmeaden, Ireland
 

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neopharmed Gentili Competitors (47)

One of Neopharmed Gentili’s 47 competitors is Genzyme Ireland, a Corporation company based in Kilmeaden, Ireland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genzyme Ireland Corporation Kilmeaden, Ireland
Pfizer (Vienna) Corporation Vienna, Austria
Evonile Pharma Private Equity-Backed Mumbai, India
Ferrer Internacional Private Debt Financed Barcelona, Spain
Pfizer Pakistan Corporation Karachi, Pakistan
You’re viewing 5 of 47 competitors. Get the full list »

Neopharmed Gentili Patents

Neopharmed Gentili Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2923701-A1 Formulation for the treatment and control of metabolic syndrome and correlated disorders Inactive 27-Mar-2014
ES-8704966-A1 Cytidine-di:phosphate-choline deriv. prepn. Inactive 29-Jan-1986
ES-551383-A0 Procedure for preparing derivatives of citidina-diphosphate-choline. (as a breakdown and with priority of the spanish patent no. 539.891 filed on january 28, 1985) Active 29-Jan-1986
ES-8609358-A1 New acylated derivs. of cytidine di:phosphate choline Inactive 28-Jan-1985
ES-539891-A0 Procedure for preparing citidine-diphosphate-choline derivatives Active 28-Jan-1985
To view Neopharmed Gentili’s complete patent history, request access »

Neopharmed Gentili Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neopharmed Gentili Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neopharmed Gentili‘s full profile, request access.

Request a free trial

Neopharmed Gentili Investments & Acquisitions (7)

Neopharmed Gentili’s most recent deal was a Buyout/LBO with BioCryst Pharmaceuticals (European ORLADEYO Business) for . The deal was made on 01-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BioCryst Pharmaceuticals (European ORLADEYO Business) 01-Oct-2025 Buyout/LBO Buildings and Property
Sanofi (Metoclopramide Product Portfolio) 01-Apr-2025 Buyout/LBO Buildings and Property
Valeas (Pharmaceuticals) 25-Jul-2022 Buyout/LBO Pharmaceuticals
Bayer (Product Portfolio for Products based on Lormetazepam) 07-Mar-2022 Buyout/LBO Other Pharmaceuticals and Biotechnology
MDM 31-Oct-2019 Buyout/LBO Therapeutic Devices
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Neopharmed Gentili Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Valeas (Pharmaceuticals) Milan, Italy 1934

Neopharmed Gentili FAQs

  • When was Neopharmed Gentili founded?

    Neopharmed Gentili was founded in 2011.

  • Where is Neopharmed Gentili headquartered?

    Neopharmed Gentili is headquartered in Milan, Italy.

  • What is the size of Neopharmed Gentili?

    Neopharmed Gentili has 380 total employees.

  • What industry is Neopharmed Gentili in?

    Neopharmed Gentili’s primary industry is Pharmaceuticals.

  • Is Neopharmed Gentili a private or public company?

    Neopharmed Gentili is a Private company.

  • What is Neopharmed Gentili’s current revenue?

    The current revenue for Neopharmed Gentili is .

  • How much funding has Neopharmed Gentili raised over time?

    Neopharmed Gentili has raised $1.28B.

  • Who are Neopharmed Gentili’s investors?

    Neuberger Berman Group, Renaissance Partners (Italy), and Mediolanum Farmaceutici have invested in Neopharmed Gentili.

  • Who are Neopharmed Gentili’s competitors?

    Genzyme Ireland, Pfizer (Vienna), Evonile Pharma, Ferrer Internacional, and Pfizer Pakistan are some of the 47 competitors of Neopharmed Gentili.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process